Skip to main navigation
Skip to search
Skip to main content
Princeton University Home
Help & FAQ
Home
Profiles
Research units
Facilities
Projects
Research output
Press/Media
Search by expertise, name or affiliation
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward
, Jay Patel
, David R. Wise
, Omar Abdel-Wahab
, Bryson D. Bennett
, Hilary A. Coller
, Justin R. Cross
, Valeria R. Fantin
, Cyrus V. Hedvat
, Alexander E. Perl
,
Joshua D. Rabinowitz
, Martin Carroll
, Shinsan M. Su
, Kim A. Sharp
, Ross L. Levine
, Craig B. Thompson
Chemistry
High Meadows Environmental Institute
Lewis-Sigler Institute for Integrative Genomics
Molecular Biology
Princeton Branch of the Ludwig Institute for Cancer Research
Research output
:
Contribution to journal
›
Article
›
peer-review
1792
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Leukemia
100%
IDH2 mutation
100%
Isocitrate Dehydrogenase 1 mutation
100%
Isocitrate Dehydrogenase 1 (IDH1)
50%
IDH mutation
50%
Chromosomal Abnormalities
16%
Cancer-related
16%
Glioma
16%
Oncometabolite
16%
All Cancer
16%
Cytogenetically Normal Acute Myeloid Leukemia
16%
Leukemia Patients
16%
Pharmacology, Toxicology and Pharmaceutical Science
Isocitrate Dehydrogenase 1
100%
Dipeptidyl Carboxypeptidase
100%
2 Hydroxyglutaric Acid
100%
Leukemia
100%
Acute Myeloid Leukemia
66%
Chromosome Aberration
16%
Neuroscience
IDH2
100%
Dipeptidyl Carboxypeptidase
100%
Isocitrate Dehydrogenase 1
100%
Biochemistry, Genetics and Molecular Biology
Isocitrate Dehydrogenase
100%
IDH2
100%
Chromosomal Abnormalities
25%